Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Comparison of Efficacy Between Permethrin 5% Cream and Ivermectin 1% Cream in Combination With Oral Doxycycline in Treatment of Papulopustular Rosacea Patients; [مقایسهی تأثیر کرم پرمترین 5 % همراه با داکسیسیکلین خوراکی با کرم ایورمکتین 1 % همراه با داکسیسیکلین خوراکی در درمان بیماران مبتلا به روزاسه پاپولوپوسچولار] Publisher



Poostiyan N1, 2, 3 ; Faghihi G1, 2, 3 ; Poostiyan E1, 2, 3 ; Zomorodian MD4 ; Sindarreh S5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Skin Diseases and Leishmaniasis Research Center, Department of Dermatology, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Skin Diseases and Leishmaniasis Research Center, Department of Dermatology, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Skin Diseases and Leishmaniasis Research Center, Department of Dermatology, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Cancer Prevention Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Isfahan Medical School Published:2024


Abstract

Background: This study aimed to compare the impact of 5% permethrin cream combined with oral doxycycline with 1% ivermectin cream combined with oral doxycycline in treating patients with papulopustular rosacea. Methods: This study was a single-blind clinical trial on papulopustular rosacea patients at Isfahan teaching hospitals. Patients were randomly divided into two groups: one receiving 5% permethrin cream with oral doxycycline and the other receiving 1% ivermectin cream with oral doxycycline. Inflammatory lesion count, IGA Score, and VAS Score were compared at 0, 6, and 12-week intervals. Findings: All 40 patients involved in the study were female, with an average age of 42.53 ± 10.4 years. The findings revealed a significant decrease in the average number of inflammatory lesions over time in both treatment groups (P < 0.05). Nevertheless, there was no notable variance in the number of inflammatory lesions over time between the two groups (P = 0.098). Additionally, the average IGA Score in both treatment cohorts significantly reduced as time progressed (P < 0.05). However, there was no significant contrast in IGA Score changes over time between the two treatment groups (P = 0.129). Patient satisfaction levels did not differ significantly between the two groups (P = 0.635). Conclusion: The results indicated that both treatments were effective in decreasing the disease severity, reducing inflammatory lesions, and lowering the IGA Score. Nevertheless, no substantial superiority of one treatment over the other was observed in this study. © 2024 Isfahan University of Medical Sciences(IUMS). All rights reserved.